Sponsor pipeline

CSL Behring clinical trial pipeline

Get alerts when CSL Behring's trials change

19 active trials 15 recruiting 7 Phase 3 4 disease areas 5 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

4 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 4 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 2
4
Phase 2/3
1
Phase 3
6
Phase 4
2
Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT03684018 Two Dose Levels of Privigen in Pediatric CIDP Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Recruiting 2026-06-01
NCT07326592 Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung… Alpha1 Antitrypsin Deficiency Not Yet Recruiting 2026-05-15
Phase 3
NCT07080905 Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to <… Hemophilia B Recruiting 2026-10-06
NCT07648264 Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to… Secondary Immune Deficiency Recruiting 2026-09-21
NCT06003387 Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With… Hemophilia B Recruiting 2026-08-27
NCT07094087 Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult… Complex Cardiovascular Surgery With Cardiopulmonary Bypass Recruiting 2026-08-18
NCT06617897 Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei… Acquired Fibrinogen Deficiency Recruiting 2026-03-11
NCT06738485 Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With… Congenital Hemophilia A Active, Not Recruiting 2026-04-23
Phase 2/3
NCT05485961 Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects… End Stage Kidney Disease Recruiting 2026-09-21
Phase 2
NCT06699849 Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle… Sickle Cell Disease Vaso-occlusive Crisis Recruiting 2026-10-08
NCT07332091 Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator… Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis Recruiting 2026-09-16
NCT07224360 Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD) Sickle Cell Disease Recruiting 2026-08-05
NCT07048262 Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With… Non-cystic Fibrosis Bronchiectasis Recruiting 2025-11-10
Phase 1
NCT07619820 A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End… End Stage Kidney Disease (ESKD) Recruiting 2026-07-07
Not specified
NCT07001280 A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients… Hereditary Angioedemas Recruiting 2026-06-03
NCT06008938 An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX®… Hemophilia B Recruiting 2026-02-19
NCT04672733 Hizentra® in Inflammatory Neuropathies - pHeNIx Study Chronic Inflammatory Demyelinating Polyneuropathy Recruiting 2025-01-07
NCT05962398 Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With… Hemophilia B Enrolling by Invitation 2025-07-18
NCT05086575 Observatory of Patients With Haemophilia B Treated by IdElvion® Haemophilia B Active, Not Recruiting 2025-01-08

Disease areas by active trials

Hemophilia (6) · Chronic Kidney Disease (2) · Sickle Cell Disease (2) · COPD (1)

Get alerts when CSL Behring's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free